Hypermarcas, Pfizer May Buy Mantecorp, Relatorio Reservado Says
Hypermarcas SA and Pfizer Inc. are considering buying Mantecorp, a Brazilian maker of generic drugs, Relatorio Reservado reported, without saying where it got the information.
Hypermarcas declined to comment on the report because it’s in a silent period before its bond sale, outside communications company Maquina da Noticia told Bloomberg News today. An official at Pfizer’s U.K. press office wasn’t immediately able to comment.
Related posts:
- Brazil Retailers Insinuante, Ricardo Eletro Plan to Merge
- Hypermarcas Agrees to Buy Luper for 52.2 Million Reais
- Hypermarcas Plans to Sell 500 Million Reais of Bonds in Brazil
- Petrobras, Sao Martinho to Start Biofuel Partnership, Valor Says
- Brazil Bond Market ‘Heating Up’ as Itausa, Taesa Plan Sales
Tags: Hypermarcas SA, Mantecorp, Pfizer Inc
This entry was posted on Tuesday, July 27th, 2010 at 12:22 pm and is filed under Stock & Bond Market News.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.









